| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $155K | +176.8% | +868.8% |
| SG&A Expense | $2.1M | +1.5% | — |
| Operating Income | -$2.3M | -6.0% | — |
| Pre-tax Income | -$3.0M | -160.9% | — |
| Net Income | -$3.0M | -160.9% | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.2M | — | — |
| Current Assets | $3.6M | — | — |
| Total Assets | $3.7M | — | — |
| Current Liabilities | $7.5M | — | — |
| Total Liabilities | $8.0M | — | — |
| Stockholders' Equity | -$4.2M | -178.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | — |
| Investing Cash Flow | -$94K | — | — |
| Financing Cash Flow | $5.8M | — | — |
| -6709.4% |